Kazia Therapeutics interim data from clinical studies reinforces positive efficacy signals2020-06-22 16:42:00 The Cantrixil phase I study is now complete and analysis is underway
Proactive investors - article 922405 - published yesterday
worth a google using that bold phrase
KZA Price at posting:
49.5¢ Sentiment: Buy Disclosure: Held